Troupin Barbara Insider Trades

Insider Trading History

Track insider trading activity for Troupin Barbara. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Equillium
Equillium EQ
Director
Holding Value $62.2k 20,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.8k 20,000 shares
$0.39
$3.11
Equillium
Equillium EQ
Director
Holding Value $0 0 shares
Last Trade
Feb 14, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$37.6k 40,000 shares
$0.94
$3.11
Equillium
Equillium EQ
Director
Holding Value $124k 40,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.6k 40,000 shares
$0.94
$3.11
Equillium
Equillium EQ
Director
Holding Value $62.2k 20,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.6k 20,000 shares
$1.43
$3.11
Equillium
Equillium EQ
Director
Holding Value $62.2k 20,000 shares
Last Trade
May 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13k 20,000 shares
$0.65
$3.11
Equillium
Equillium EQ
Director
Holding Value $124k 40,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 40,000 shares
$3.59
$3.11
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Medical Officer
Holding Value $262k 75,000 shares
Last Trade
Mar 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Medical Officer
Holding Value $140k 40,000 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Medical Officer
Holding Value $175k 50,000 shares
Last Trade
Nov 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Seelos Therapeutics
Seelos Therapeutics SEEL
Svp, Chief Medical Officer
Holding Value $74k 200,000 shares
Last Trade
Mar 15, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256B 200,000 shares
$1,281,278.72
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Chief Medical Officer
Holding Value $18.5k 50,000 shares
Last Trade
Jan 29, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.5B 50,000 shares
$1,650,656.37
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Chief Medical Officer
Holding Value $111k 300,000 shares
Last Trade
Dec 12, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$402B 300,000 shares
$1,338,993.98
$0.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up